New Releases from NCBI BookshelfTezepelumab for treating severe asthma.Tezepelumab for treating severe asthma.
Post Content
March 20, 2025
Uncategorized
New Releases from NCBI BookshelfTrastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after anti-HER2 treatment (terminated appraisal).Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after anti-HER2 treatment (terminated appraisal).
Post Content
Uncategorized
New Releases from NCBI BookshelfBenefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT.Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT.
Chronic kidney disease affects around 10% of the global population and is associated with significant risk of progression to end-stage
